Early prediction of blonanserin response in Japanese patients with schizophrenia
Taro Kishi,1 Yuki Matsuda,1 Kiyoshi Fujita,2,3 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, Japan; 3The Neuroscience Research Center, Toyoake, Aichi, Japan Background: Blon...
Main Authors: | Kishi T, Matsuda Y, Fujita K, Iwata N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/early-prediction-of-blonanserin-response-in-japanese-patients-with-sch-peer-reviewed-article-NDT |
Similar Items
-
Profile of blonanserin for the treatment of schizophrenia
by: Tenjin T, et al.
Published: (2013-04-01) -
Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances
by: Yoshifumi Inoue, et al.
Published: (2021-01-01) -
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
by: Mitsukuni Murasaki, et al.
Published: (2021-09-01) -
SWITCHING ANTIPSYCHOTICS TO BLONANSERIN IN PATIENTS WITH SCHIZOPHRENIA: AN OPEN-LABEL, PROSPECTIVE, MULTICENTER STUDY
by: Kwang-Hun Lee, et al.
Published: (2023-10-01) -
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
by: Kishi T, et al.
Published: (2015-02-01)